Growth Hormone Response to L-Arginine Alone and Combined with Different Doses of Growth Hormone-Releasing Hormone: A Systematic Review and Meta-Analysis
- PMID: 36467462
- PMCID: PMC9712012
- DOI: 10.1155/2022/8739289
Growth Hormone Response to L-Arginine Alone and Combined with Different Doses of Growth Hormone-Releasing Hormone: A Systematic Review and Meta-Analysis
Abstract
Background: Arginine (ARG) can modulate growth hormone (GH) release by suppressing its endogenous inhibitory regulator, somatostatin. ARG also induces the release of the GH-releasing hormone (GHRH). This study aims to review the effects of L-arginine supplementation alone and combined with GHRH in different doses on GH secretion.
Methods: In this systematic review and meta-analysis, an electronic literature search was conducted on Medline database (PubMed), Scopus, and Web of Science databases. All eligible studies were randomized clinical trials that reported the effects of ARG supplementation alone or with GHRH on GH levels. Mean difference (MD) and 95% confidence intervals (CI) were computed as the effect size.
Results: Meta-analyses showed significant effects of ARG alone on GH release (MD = 10.07, 95% CI: 7.87, 12.28). Moreover, the response of GH was greater with ARG in combination with GHRH (MD = 24.96, 95% CI: 17.51, 32.42). There was no significant difference between the patients and healthy individuals and between oral and injection use of ARG. The systematic review revealed the important role of ARG in combination with other amino acids on GH secretion in patients with GH deficiency.
Conclusion: This study revealed that in GH-deficient individuals, high doses of ARG supplementation in combination with GHRH and/or other amino acids might have potential therapeutic effects on increasing GH concentrations. These findings propose that ARG supplementation can be considered as a potential stimulator in management of GH deficiency.
Copyright © 2022 Parvin Goli et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures





Similar articles
-
Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.J Clin Endocrinol Metab. 1988 Dec;67(6):1186-9. doi: 10.1210/jcem-67-6-1186. J Clin Endocrinol Metab. 1988. PMID: 2903866
-
Low doses of either intravenously or orally administered arginine are able to enhance growth hormone response to growth hormone releasing hormone in elderly subjects.J Endocrinol Invest. 1994 Feb;17(2):113-7. doi: 10.1007/BF03347695. J Endocrinol Invest. 1994. PMID: 8006330 Clinical Trial.
-
Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine.Clin Endocrinol (Oxf). 1990 Jun;32(6):763-7. doi: 10.1111/j.1365-2265.1990.tb00923.x. Clin Endocrinol (Oxf). 1990. PMID: 1974484 Clinical Trial.
-
Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine.Clin Endocrinol (Oxf). 1995 Dec;43(6):665-9. doi: 10.1111/j.1365-2265.1995.tb00532.x. Clin Endocrinol (Oxf). 1995. PMID: 8736266
-
Clinical review: Is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency?J Clin Endocrinol Metab. 2009 Aug;94(8):2702-7. doi: 10.1210/jc.2009-0299. Epub 2009 Jun 9. J Clin Endocrinol Metab. 2009. PMID: 19509104 Review.
Cited by
-
Sex-induced alterations in rumen microbial communities and metabolite profiles: implications for lamb body weight.BMC Microbiol. 2025 May 27;25(1):328. doi: 10.1186/s12866-025-04049-6. BMC Microbiol. 2025. PMID: 40426040 Free PMC article.
-
Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyond.Rev Endocr Metab Disord. 2025 Jun;26(3):321-342. doi: 10.1007/s11154-024-09933-6. Epub 2024 Nov 23. Rev Endocr Metab Disord. 2025. PMID: 39579280 Review.
-
The Effects of a Novel Astragalus-Based Extract (Keyfobell Powder (KFB)) on Longitudinal Bone Growth via IGF-1 Upregulation: A Potential Growth Hormone Alternative.Nutrients. 2025 Jan 23;17(3):416. doi: 10.3390/nu17030416. Nutrients. 2025. PMID: 39940274 Free PMC article.
-
The Effectiveness of L-arginine in Clinical Conditions Associated with Hypoxia.Int J Mol Sci. 2023 May 3;24(9):8205. doi: 10.3390/ijms24098205. Int J Mol Sci. 2023. PMID: 37175912 Free PMC article. Review.
-
Association between Childhood Overweight and Altered Concentrations of Circulating Amino Acids.Nutrients. 2024 Jun 12;16(12):1843. doi: 10.3390/nu16121843. Nutrients. 2024. PMID: 38931197 Free PMC article.
References
-
- Chapman I. M., Hartman M., Straume M., Johnson M., Veldhuis J. D., Thorner M. Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. Journal of Clinical Endocrinology and Metabolism . 1994;78(6):1312–1319. doi: 10.1210/jc.78.6.1312. - DOI - PubMed
-
- Ali Imarah A., Subhi Mohammed M., Ahmed Najm R., Al Zeyadi M., Khayoon S. Q., Alhamadani I. Effect of the concentration levels of growth hormone and insulin-like growth factor I on the polymorphisms of the Il12p40 gene in lung cancer patients. Archives of Razi Institute . 2022;77(1):413–419. doi: 10.22092/ARI.2021.356610.1880. - DOI - PMC - PubMed
-
- Matteini M., Cotrozzi G., Zammarchi E., Relli P., Cappelli G. GH secretion by arginine stimulus: the effect of both low doses and oral arginine administered before standard test. Bollettino della Societa italiana di biologia sperimentale . 1980;56(21):2254–2260. - PubMed
-
- Maccario M., Aimaretti G., Grottoli S., et al. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency. International Journal of Obesity . 2001;25(8):1233–1239. doi: 10.1038/sj.ijo.0801671. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources